Return to Listing

1 result(s) for ABL001

PI Name Protocol # Title
Michael Heinrich IRB00010537 A Phase I, Multicenter, Open-Label Study of Oral ABL001 in Patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080